Publications Database

Aman M. G. et al. (2010)

Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

20(5), pp. 415-422.

Read Abstract (New Window)

Findling R. L. et al. (2014)

A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorder.

Journal of Clinical Psychiatry

75(1), pp. 22-30,

Read Abstract (New Window)

Mankoski R. et al. (2013)

Aripiprazole treatment of irritability associated with autistic disorder and the relationship between prior antipsychotic exposure, adverse events, and weight change.

Journal of Child and Adolescent Psychopharmacology

23(8), pp. 572-576.

Read Abstract (New Window)

Marcus R. N. et al. (2009)

A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

48(11), pp. 1110-1119

Read Abstract (New Window)

Marcus R. N. et al. (2011)

Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study.

Journal of Child and Adolescent Psychopharmacology

21(3), pp. 229-236

Read Abstract (New Window)

Marcus R. N. et al. (2011)

Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study.

Journal of Clinical Psychiatry

72(9), pp. 1270-1276.

Read Abstract (New Window)

Owen R. et al. (2009)

Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.

Pediatrics

124(6), pp. 1533-1540.

Read Abstract (New Window) Read Full (New Window)

Robb A. S. et al. (2011)

Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6-17 years old):results from a pooled analysis of 2 studies.

Primary Care Companion to CNS Disorders

13(1), pii: PCC.10m01008

Read Abstract (New Window) Read Full (New Window)

Varni J. W. et al. (2012)

Effect of aripiprazole 2 to 15 mg/d on health-related quality of life in the treatment of irritability associated with autistic disorder in children: A post hoc analysis of two controlled trials.

Clinical Therapeutics

34(4), pp. 980-992.

Read Abstract (New Window)